Friday, March 17, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

B3 Solutions Selected for JPEO Chem-Bio Defense Omnibus Support

by Global Biodefense Staff
March 20, 2013

B3 Solutions, LLC. this week announced it has been awarded a prime position on the Acquisition Domain of the Omnibus Program Engineering and Technical Support contract supporting the development and fielding of chemical and biological defense materiel for the Department of Defense Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).

The five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract expands B3 Solutions’ presence at JPEO-CBD. Including B3 Solutions, there are 22 awardees in the Acquisition Domain. All awardees have the potential to receive the full value amount of the IDIQ contract if all options are exercised.

B3 Solutions will compete for JPEO-CBD task orders to provide acquisition, program management and relations management in CBD and national security communities, strategic planning, program analysis, life cycle management, international program analysis on foreign military sales, equipment expertise on the production and usage of CBD protective equipment, multimedia, graphics, technical writing support, and administrative support.

“We look forward to providing the critical expertise required to help develop chemical and biological defense solutions,” said William Almas, B3 Solutions CEO. “Nothing is more important than keeping our armed forces and civilians out of harm’s way.”

The JPEO-CBD is responsible for research, development and acquisition support of chemical, biological, radiological, and nuclear defense equipment and medical countermeasures for missions overseas and at home.

Source: B3 Solutions 

Tags: AwardsJPEO-CBRND

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States
Industry News

Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States

September 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy